TOP STORIES
There was direct and indirect blowback after the Eli Lilly heart drug announcement. Lilly’s stock dropped almost eight percent and analysts were cutting 2020 sales projections by five percent. There was also nuance amid the evacetrapib failure, though: Lilly’s pipeline could provide get it through this.
However, Lilly wasn’t the only company to take shrapnel over the announcement.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The odds that Merck & Co’s high-stakes cholesterol drug will succeed have dropped dramatically after Eli Lilly and Co said its similar medicine failed to reduce heart attacks and strokes.
Stay tuned. – Wall Street Journal, Pharmlot and Reuters
Forbes editor and minor healthcare rockstar Avik Roy has joined Marco Rubio’s campaign (Roy had been with Rick Perry’s campaign). – The Hill
No candidate expresses—and embodies—the American dream better than @MarcoRubio. I’m honored to be advising Sen. Rubio on policy. @TeamMarco
— Avik Roy (@Avik) October 12, 2015
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
LIFE SCIENCES
New York’s attorney general is looking into Turing Pharmaceuticals. It’s not so much for the price increase but whether Turing violated antitrust laws by restricting Daraprim’s distribution. – The New York Times
Just in time for the Democratic presidential debate: U.S. prices for the world’s 20 top-selling medicines are about three times higher than in Britain. – Reuters
St. Jude Medical’s HeartMate 3 implantable heart pump won its CE Mark. – MassDevice
Varian Medical’s latest proton therapy system has been approved for Europe. – MassDevice
Seattle is almost out of quality space to house biotech companies. – Puget Sound Business Journal
PAYERS-PROVIDERS
Inside the mind of consumers: 73 percent trust their hospital while 49 percent trust their health insurance provider, according to new research on patients’ points of view. – Becker’s Hospital Review
Another study shows hospital gowns are nothing more than an iconic anachronism that cause more trouble than they are worth. Hospital gowns transferred bacteria to clothing beneath almost half the time. – Los Angeles Times
In a not-shocking development, doctors would prefer retail clinics serve as a backup to a patient’s regular doctor. How quaint. – Reuters
A nurses union alliance is almost over: the California Nurses Association and National Union of Healthcare Workers are likely to separate. – San Francisco Business Times
The Texas Medical Association has come out against the Aetna-Humana merger. – San Antonio Business Journal
TECHNOLOGY
CareFirst BlueCross BlueShield will award $3 million to nonprofits or government organizations to develop new programs using telemedicine around in the Washington, D.C-area. – Baltimore Business Journal
Wearables company Movable has been acquired by DHS Group. – Houston Business Journal
Doctolib, a French version of ZocDoc, raised $20.5 million to expand across Europe. – VentureBeat
German women’s fertility mobile app Clue has raised $7 million. – MobiHealthNews
Take a look at Children’s Hospital Los Angeles’s sickle cell app, R-Helper. – iMedicalApps
Probably no healthcare impact, but just in case: Stephen Gillett, former COO at Symantec, is joining Google Ventures as an executive in residence. – TechCrunch
POLITICS
Healthcare.gov is getting a facelift to make it easier to find health plans. – The New York Times
Jeb Bush said he would repeal Obamacare. – Associated Press
A LITTLE BIT EXTRA
The Democratic presidential debate is tonight. Here’s something I bet you did not know: there are five candidates. – ABC & NPR
